Literature DB >> 7756605

Localization of 5-HT3 receptors in the rat spinal cord: immunohistochemistry and in situ hybridization.

H K Kia1, M C Miquel, R M McKernan, A M Laporte, M C Lombard, S Bourgoin, M Hamon, D Vergé.   

Abstract

Specific antibodies raised against a fusion protein containing the amino acid sequence of the putative second intracellular loop of the cloned 5-HT3-A receptor subunit were used for the immunohistochemical visualization of 5-HT3 receptors in the rat spinal cord. A dense 5-HT3-like immunoreactivity was found in the superficial layers of the dorsal horn, which closely matched the labelling of 5-HT3 binding sites by [125I]iodo-zacopride. This immunostaining was markedly decreased following unilateral rhizotomy, consistently with a preferential location of 5-HT3 receptors on terminals of primary afferent fibres, and with the presence of 5-HT3 mRNA in dorsal root ganglia. However, a significant proportion of 5-HT3 receptors persisted after rhizotomy, and the corresponding mRNA was found in the dorsal horn of the spinal cord. 5-HT3 receptors are therefore also located on intrinsic neurones of the spinal cord.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7756605     DOI: 10.1097/00001756-199501000-00008

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  21 in total

1.  The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors.

Authors:  Karla P Zeitz; Nicolas Guy; Annika B Malmberg; Sahera Dirajlal; William J Martin; Linda Sun; Douglas W Bonhaus; Cheryl L Stucky; David Julius; Allan I Basbaum
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

2.  Joint manipulation reduces hyperalgesia by activation of monoamine receptors but not opioid or GABA receptors in the spinal cord.

Authors:  D A Skyba; R Radhakrishnan; J J Rohlwing; A Wright; K A Sluka
Journal:  Pain       Date:  2003-11       Impact factor: 6.961

3.  Spinal 5-HT-receptors and tonic modulation of transmission through a withdrawal reflex pathway in the decerebrated rabbit.

Authors:  R W Clarke; J Harris; A K Houghton
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 4.  Neuropathic Pain After Spinal Cord Injury: Challenges and Research Perspectives.

Authors:  Rani Shiao; Corinne A Lee-Kubli
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

5.  Descending serotonergic facilitation of spinal ERK activation and pain behavior.

Authors:  Camilla I Svensson; Thao K Tran; Bethany Fitzsimmons; Tony L Yaksh; Xiao-Ying Hua
Journal:  FEBS Lett       Date:  2006-11-14       Impact factor: 4.124

Review 6.  The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.

Authors:  A J Greenshaw; P H Silverstone
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

Review 7.  The 5-HT3 receptor as a therapeutic target.

Authors:  Andrew J Thompson; Sarah C R Lummis
Journal:  Expert Opin Ther Targets       Date:  2007-04       Impact factor: 6.902

8.  5-hydroxytryptamine type 3 receptor modulates opioid-induced hyperalgesia and tolerance in mice.

Authors:  De-Yong Liang; XiangQi Li; J David Clark
Journal:  Anesthesiology       Date:  2011-05       Impact factor: 7.892

9.  Modulation of afferent-evoked neurotransmission by 5-HT3 receptors in young rat dorsal horn neurones in vitro: a putative mechanism of 5-HT3 induced anti-nociception.

Authors:  S G Khasabov; J A Lopez-Garcia; A U Asghar; A E King
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

10.  The 5-HT(3) receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat.

Authors:  C M Kozlowski; A Green; D Grundy; F M Boissonade; C Bountra
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.